NO3051026T3 - - Google Patents

Info

Publication number
NO3051026T3
NO3051026T3 NO16160669A NO16160669A NO3051026T3 NO 3051026 T3 NO3051026 T3 NO 3051026T3 NO 16160669 A NO16160669 A NO 16160669A NO 16160669 A NO16160669 A NO 16160669A NO 3051026 T3 NO3051026 T3 NO 3051026T3
Authority
NO
Norway
Application number
NO16160669A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO3051026T3 publication Critical patent/NO3051026T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
NO16160669A 2011-10-21 2009-04-01 NO3051026T3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161550148P 2011-10-21 2011-10-21

Publications (1)

Publication Number Publication Date
NO3051026T3 true NO3051026T3 (ru) 2018-07-28

Family

ID=48136439

Family Applications (1)

Application Number Title Priority Date Filing Date
NO16160669A NO3051026T3 (ru) 2011-10-21 2009-04-01

Country Status (18)

Country Link
US (6) US20150087525A1 (ru)
EP (2) EP2768986B1 (ru)
JP (2) JP6159727B2 (ru)
KR (2) KR101912731B1 (ru)
CN (2) CN104145024A (ru)
AU (1) AU2012356317B2 (ru)
BR (2) BR112014009643B1 (ru)
CA (1) CA2852850C (ru)
DK (2) DK2944700T3 (ru)
ES (2) ES2662401T3 (ru)
HU (2) HUE035614T2 (ru)
IN (1) IN2015DN01855A (ru)
MX (2) MX357550B (ru)
NO (1) NO3051026T3 (ru)
PL (2) PL2944700T3 (ru)
PT (2) PT2944700T (ru)
RU (2) RU2662975C1 (ru)
WO (1) WO2013093635A2 (ru)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2825522A1 (en) 2011-01-26 2012-08-02 Cepheid Methods of detecting lung cancer
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
IL269097B2 (en) 2012-09-04 2024-01-01 Guardant Health Inc Systems and methods for detecting rare mutations and changes in number of copies
US10876152B2 (en) 2012-09-04 2020-12-29 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US11913065B2 (en) 2012-09-04 2024-02-27 Guardent Health, Inc. Systems and methods to detect rare mutations and copy number variation
CA2934822A1 (en) 2013-12-28 2015-07-02 Guardant Health, Inc. Methods and systems for detecting genetic variants
US10260105B2 (en) 2014-02-18 2019-04-16 Baylor Research Institute MiR-320e and colorectal cancer
KR20240023185A (ko) * 2014-06-13 2024-02-20 도레이 카부시키가이샤 대장암의 검출 키트 또는 디바이스 및 검출 방법
WO2016034715A2 (fr) * 2014-09-05 2016-03-10 Prestizia Methode de prediction de l'evolution clinique du cancer colorectal
CN104313142B (zh) * 2014-10-16 2016-02-03 上海交通大学医学院附属仁济医院 miRNA-30a作为标记分子在制备诊断试剂中的用途
CN104388541B (zh) * 2014-10-21 2017-07-04 复旦大学附属肿瘤医院 miR‑1914*和miR‑1915的用途
CN104372004B (zh) * 2014-12-04 2018-04-27 广东医学院 一个与心肌梗死易感相关的miR-27a基因单核苷酸多态位点的检测方法及其应用
EP3147370A1 (en) 2015-09-28 2017-03-29 Rheinische Friedrich-Wilhelms-Universität Bonn Exosomal microrna in serum as an indicator for the activation of brown and beige fat tissue (bat)
SG11201805119QA (en) 2015-12-17 2018-07-30 Guardant Health Inc Methods to determine tumor gene copy number by analysis of cell-free dna
AU2017313455A1 (en) * 2016-08-18 2019-12-12 Samantha KHOURY Biomarkers of oral, pharyngeal and laryngeal cancers
EP3327135A1 (en) * 2016-11-28 2018-05-30 Advanced Marker Discovery, S.L. In vitro method for identifying colorectal adenomas or colorectal cancer
CN106950370A (zh) * 2017-01-25 2017-07-14 上海市第十人民医院 血液微小核酸大肠癌诊断分子组合
CN107254522A (zh) * 2017-06-09 2017-10-17 中山大学附属第三医院 miR‑664a‑5p的检测试剂在制备肝癌诊断试剂/试剂盒中的应用
CN107236799B (zh) * 2017-06-15 2020-06-09 昆明医科大学第六附属医院 一种肾纤维化miRNA标记物
CN107326092B (zh) * 2017-08-25 2021-07-20 深圳市恩普电子技术有限公司 大肠癌相关的miRNA作为生物标志物的应用及大肠癌检测试剂盒
CN107746886B (zh) * 2017-09-11 2019-10-01 朱伟 一种与结直肠癌辅助诊断相关的血浆miRNA标志物及其应用
WO2019144183A1 (en) * 2018-01-23 2019-08-01 La Trobe University Biomarkers of colorectal cancer
CA3090785A1 (en) 2018-02-14 2019-08-22 John Daniel Dobak Iii Novel gene classifiers and uses thereof in non-melanoma skin cancers
CN110205367B (zh) * 2018-02-28 2022-06-21 伽蓝(集团)股份有限公司 一种筛选保护皮肤细胞端粒的活性物的方法
WO2019217478A1 (en) * 2018-05-09 2019-11-14 Dermtech, Inc. Novel gene classifiers and uses thereof in autoimmune diseases
CN108753974B (zh) * 2018-06-27 2022-05-06 深圳华大生命科学研究院 一种结直肠癌肿瘤标志物及其检测方法与装置
CN109557311B (zh) * 2018-12-13 2022-02-15 中南大学湘雅医院 结直肠癌诊断标志物及结直肠癌的检测产品及其应用
KR102275465B1 (ko) * 2019-01-18 2021-07-09 사회복지법인 삼성생명공익재단 전이성 대장암 치료물질 스크리닝 방법
CN112041463A (zh) * 2019-03-11 2020-12-04 香港中文大学 结肠直肠癌的miRNA标志物
CN110438227A (zh) * 2019-07-29 2019-11-12 广州中昱医学生物科技有限公司 miR-17-92在结直肠癌诊断中的用途
CN112080568A (zh) * 2020-09-27 2020-12-15 扬州大学 一种与湖羊肌肉细胞增殖相关的miRNA标志物及其检测引物和应用
WO2023032452A1 (ja) * 2021-08-31 2023-03-09 国立大学法人大阪大学 2型糖尿病・大腸がんを検査する方法
WO2023036266A1 (en) * 2021-09-08 2023-03-16 Guangdong Jiyin Biotech Co. Ltd Compositions and methods for diagnosing colorectal cancer
CN113981096A (zh) * 2021-11-30 2022-01-28 无锡市疾病预防控制中心 一种用于诊断结直肠癌的血浆miRNA标志物及其应用
WO2023222927A2 (en) 2022-05-20 2023-11-23 Novigenix Sa Biomarkers for colorectal neoplasia

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
GB0415277D0 (en) * 2004-07-07 2004-08-11 Colonix Ltd Apparatus and method for sampling mucosal surfaces
US7939255B2 (en) 2006-07-03 2011-05-10 Catholic University Industry Academy Cooperation Foundation Diagnostic methods for colorectal cancer
US8343719B2 (en) * 2006-10-30 2013-01-01 Research Foundation Of State University Of New York Microrna as biomarker in cancer
ES2425416T3 (es) 2006-11-01 2013-10-15 The Ohio State University Research Foundation Firma de expresión del microARN para predecir la supervivencia y la metástasis en el carcinoma hepatocelular
BRPI0818146A2 (pt) * 2007-10-30 2015-07-14 Veridex Llc Processo para monitorar câncer colorretal
CN101424640B (zh) * 2007-11-02 2012-07-25 江苏命码生物科技有限公司 血清中微小核糖核酸的检测方法和用于检测的试剂盒、生物芯片及其制作和应用方法
EP2268832A2 (en) * 2008-03-06 2011-01-05 Asuragen, INC. Microrna markers for recurrence of colorectal cancer
JP2011520454A (ja) * 2008-05-16 2011-07-21 ベリデックス・エルエルシー 結腸直腸癌を評価する方法及びかかる方法に使用するための組成物
WO2010004562A2 (en) 2008-07-09 2010-01-14 Rosetta Genomics Ltd. Methods and compositions for detecting colorectal cancer
GB2463401B (en) * 2008-11-12 2014-01-29 Caris Life Sciences Luxembourg Holdings S A R L Characterizing prostate disorders by analysis of microvesicles
US9074206B2 (en) * 2008-11-13 2015-07-07 Fudan University Compositions and methods for micro-RNA expression profiling of colorectal cancer
WO2010126355A1 (en) * 2009-04-29 2010-11-04 Academisch Medisch Centrum Bij De Universiteit Van Amsterdam Means and methods for counteracting, preventing and/or determining heart failure, or a risk of heart failure
US20100317533A1 (en) 2009-06-05 2010-12-16 British Columbia Cancer Agency Branch Biomarkers of cancer metastasis
EP2336353A1 (en) * 2009-12-17 2011-06-22 febit holding GmbH miRNA fingerprints in the diagnosis of diseases
WO2011012136A1 (en) 2009-07-28 2011-02-03 Exiqon A/S A method for classifying a human cell sample as cancerous
CN101988060A (zh) * 2009-07-30 2011-03-23 江苏命码生物科技有限公司 结直肠癌检测标记物及其检测方法、试剂盒和生物芯片
AR078584A1 (es) * 2009-10-09 2011-11-16 Baylor Res Inst Identificacion de microarn (miarn) en muestras fecales como biomarcador de canceres gastroenterologicos
WO2011076147A1 (en) 2009-12-24 2011-06-30 Fudan University Plasma-based micro-rna biomarkers and methods for early detection of colorectal cancer
WO2011076142A1 (en) * 2009-12-24 2011-06-30 Fudan University Compositions and methods for microrna expession profiling in plasma of colorectal cancer
CA2787027A1 (en) 2010-01-13 2011-07-21 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Detection of gastrointestinal disorders
WO2011160585A1 (en) * 2010-06-23 2011-12-29 The Chinese University Of Hong Kong Micro-rna markers for colorectal cancer

Also Published As

Publication number Publication date
CN104651521B (zh) 2021-08-27
RU2611189C2 (ru) 2017-02-21
CN104651521A (zh) 2015-05-27
DK2768986T3 (en) 2018-09-10
BR122015004941A2 (pt) 2019-08-20
KR101912731B1 (ko) 2018-10-29
JP2014530619A (ja) 2014-11-20
KR20150036804A (ko) 2015-04-07
PT2944700T (pt) 2018-01-24
HUE035614T2 (en) 2018-05-28
DK2944700T3 (en) 2018-01-22
US20150176082A1 (en) 2015-06-25
BR112014009643B1 (pt) 2020-12-15
JP6203209B2 (ja) 2017-09-27
MX2014004810A (es) 2014-11-25
KR101900872B1 (ko) 2018-09-20
US20180346996A1 (en) 2018-12-06
US20180355439A1 (en) 2018-12-13
AU2012356317A1 (en) 2014-05-15
EP2944700A1 (en) 2015-11-18
BR122015004941B1 (pt) 2021-09-28
HUE039522T2 (hu) 2019-01-28
RU2662975C1 (ru) 2018-07-31
EP2768986B1 (en) 2018-06-27
KR20140097195A (ko) 2014-08-06
MX357550B (es) 2018-07-13
BR112014009643A2 (pt) 2017-12-12
US20130102487A1 (en) 2013-04-25
ES2662401T3 (es) 2018-04-06
IN2015DN01855A (ru) 2015-07-10
PL2768986T3 (pl) 2018-12-31
AU2012356317B2 (en) 2016-04-07
PL2944700T3 (pl) 2018-05-30
EP2768986A2 (en) 2014-08-27
WO2013093635A2 (en) 2013-06-27
CN104145024A (zh) 2014-11-12
EP2944700B1 (en) 2017-10-18
CA2852850A1 (en) 2013-06-27
MX357119B (es) 2018-06-27
US20150087525A1 (en) 2015-03-26
JP2015128442A (ja) 2015-07-16
CA2852850C (en) 2020-07-28
WO2013093635A3 (en) 2013-09-06
RU2014120427A (ru) 2015-11-27
ES2688693T3 (es) 2018-11-06
PT2768986T (pt) 2018-10-23
US20160289771A1 (en) 2016-10-06
JP6159727B2 (ja) 2017-07-05

Similar Documents

Publication Publication Date Title
BR112012012396A2 (ru)
BR112012008267A2 (ru)
BR112012008195A2 (ru)
BR112012000607A2 (ru)
BRPI0924307A2 (ru)
BR112012003080A2 (ru)
BR122021004633A2 (ru)
BR122017024704A2 (ru)
BR112012012487A2 (ru)
BR112012000665A2 (ru)
BR112012003853A2 (ru)
NO3051026T3 (ru)
BR112012012080A2 (ru)
BR112012010357A2 (ru)
BR112012007656A2 (ru)
BR122019005883A2 (ru)
BR112012002627A2 (ru)
BR112012001263A2 (ru)
BR112012000159A2 (ru)
BRPI1004942A2 (ru)
BR112012014856A2 (ru)
BRPI0924534A2 (ru)
BR112012007654A2 (ru)
BR112012007672A2 (ru)
BR112012005951A2 (ru)